Provided by Tiger Fintech (Singapore) Pte. Ltd.

Milestone Pharmaceuticals Inc.

2.38
-0.0300-1.24%
Post-market: 2.30-0.0800-3.36%16:56 EDT
Volume:2.79M
Turnover:6.36M
Market Cap:126.98M
PE:-3.14
High:2.46
Open:2.45
Low:2.16
Close:2.41
Loading ...

Milestone Pharmaceuticals Inc - Enters Amended and Restated Open Market Sale Agreement With Jefferies - SEC Filing

THOMSON REUTERS
·
24 mins ago

Milestone Pharmaceuticals Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
17 Mar

Milestone Pharmaceuticals’ SEC Exemptions: Balancing Reduced Disclosure with Investor Confidence Risks

TIPRANKS
·
14 Mar

Milestone Pharmaceuticals: Q4 Earnings Snapshot

Associated Press Finance
·
13 Mar

Milestone Pharmaceuticals FY 2024 GAAP EPS $(0.67) Misses $(0.62) Estimate, Cash Balance Of $69.7M

Benzinga
·
13 Mar

Milestone Pharmaceuticals Inc: Q4 Shr Loss $-0.19

THOMSON REUTERS
·
13 Mar

Press Release: Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update

Dow Jones
·
13 Mar

Milestone Pharmaceuticals reports inducement grants under Nasdaq listing rule

TIPRANKS
·
04 Mar

TD Cowen Keeps Their Buy Rating on Milestone Pharmaceuticals (MIST)

TIPRANKS
·
02 Mar

Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Milestone Pharmaceuticals (MIST) and Personalis (PSNL)

TIPRANKS
·
28 Feb

Milestone Pharmaceuticals Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
28 Feb

DONNA KARAN CASHMERE MIST INTRODUCES A NEW CHAPTER FOR SPRING 2025, FEATURING IMAAN HAMMAM IN A CAPTIVATING CAMPAIGN

PR Newswire
·
28 Feb

Milestone Pharmaceuticals Gets Notice of Allowance for US Patent on Etripamil Nasal Spray

MT Newswires Live
·
19 Feb

BRIEF-Milestone Pharmaceuticals Inc Receives Notice Of Allowance On New U.S. Patent For Etripamil

Reuters
·
19 Feb

Milestone receives notice of allawance from USPTO on etripamil nasal spray

TIPRANKS
·
19 Feb

Milestone Pharmaceuticals Inc: Receives Notice of Allowance on New U.S. Patent for Etripamil

THOMSON REUTERS
·
19 Feb